Boston Scientific Corp (BSX)vsCanadian Natural Resources Ltd (CNQ)
BSX
Boston Scientific Corp
$69.17
-1.43%
HEALTHCARE · Cap: $101.28B
CNQ
Canadian Natural Resources Ltd
$50.09
+2.92%
ENERGY · Cap: $101.52B
Smart Verdict
WallStSmart Research — data-driven comparison
Canadian Natural Resources Ltd generates 93% more annual revenue ($38.76B vs $20.07B). CNQ leads profitability with a 27.9% profit margin vs 14.4%. BSX appears more attractively valued with a PEG of 0.75. CNQ earns a higher WallStSmart Score of 67/100 (B-).
BSX
Buy63
out of 100
Grade: C+
CNQ
Strong Buy67
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+2.0%
Fair Value
$70.62
Current Price
$69.17
$1.45 discount
Margin of Safety
+76.8%
Fair Value
$175.50
Current Price
$50.09
$125.41 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Growing faster than its price suggests
15.9% revenue growth
Generating 1.0B in free cash flow
Revenue surging 150.0% year-over-year
Earnings expanding 372.3% YoY
Large-cap with strong market position
Every $100 of equity generates 26 in profit
Keeps 28 of every $100 in revenue as profit
Attractively priced relative to earnings
Areas to Watch
Premium valuation, high expectations priced in
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.
Bull Case : CNQ
The strongest argument for CNQ centers on Revenue Growth, EPS Growth, Market Cap. Profitability is solid with margins at 27.9% and operating margin at 19.6%. Revenue growth of 150.0% demonstrates continued momentum.
Bear Case : BSX
The primary concerns for BSX are P/E Ratio.
Bear Case : CNQ
The primary concerns for CNQ are PEG Ratio.
Key Dynamics to Monitor
CNQ carries more volatility with a beta of 1.06 — expect wider price swings.
CNQ is growing revenue faster at 150.0% — sustainability is the question.
CNQ generates stronger free cash flow (2.3B), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
CNQ scores higher overall (67/100 vs 63/100), backed by strong 27.9% margins and 150.0% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Canadian Natural Resources Ltd
ENERGY · OIL & GAS E&P · USA
Canadian Natural Resources Limited acquires, explores, develops, produces, markets and sells crude oil, natural gas and natural gas liquids (NGL). The company is headquartered in Calgary, Canada.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?